Check-Cap Building
29 Abba Hushi Avenue PO Box 1271
Isfiya 3009000
Israel
972 4 830 3401
https://www.check-cap.com
Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno: 85
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Alex Ovadia | CEO & Director | 409,35k | N/D | 1962 |
Dr. Yoav Kimchy Ph.D. | Founder & Interim CTO | 362,65k | N/D | 1961 |
Mr. Joshua Belkar | Vice President of Operations | 269,57k | N/D | 1969 |
Ms. Mira Rosenzweig | Executive Officer | 287,99k | N/D | 1972 |
Ms. Iris Even-Tov | Interim Chief Financial Officer | N/D | N/D | N/D |
Ms. Noa Reshef M.B.A. | Director of Human Resources | N/D | N/D | N/D |
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
L'ISS Governance QualityScore di Check-Cap Ltd. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.